Treatment of a Tuberculous Empyema with Simultaneous Oral and Intrapleural Antituberculosis Drugs | Zendy

Richard Long | Zendy; J Barrié | Zendy; Kenneth Stewart | Zendy; Charles A. Peloquin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of a Tuberculous Empyema with Simultaneous Oral and Intrapleural Antituberculosis Drugs

Author(s) -

Richard Long,

J Barrié,

Kenneth Stewart,

Charles A. Peloquin

Publication year - 2008

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2008/747206

Subject(s) - medicine , empyema , tuberculosis , drug , surgery , thoracentesis , context (archaeology) , drug resistance , thoracostomy , pleural effusion , pharmacology , pathology , paleontology , pneumothorax , biology , microbiology and biotechnology

A 71-year-old man was diagnosed with an uncomplicated tuberculous (TB) empyema. Differential penetration of anti-TB drugs, believed to explain the phenomenon of acquired drug resistance in TB empyema, was confirmed by measurement of serum and pleural fluid anti-TB drug concentrations. Simultaneous oral and intrapleural anti-TB drugs were administered and a cure was achieved. The present case is discussed in the context of the literature on acquired drug resistance in TB empyema. It is argued that high-end doses of oral drugs or combined oral plus intrapleural drugs, along with tube thoracostomy or intermittent thoracentesis, will cure uncomplicated TB empyema without threatening to induce drug resistance or having to resort to surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research